Shimodaira Y - Search Results

1

Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents.

Shiga H, Takahashi T, Shiraki M, Kojima Y, Tsuji T, Takagi S, Hiramoto K, Yokoyama N, Sugimura M, Iwabuchi M, Endo K, Onodera M, Sato Y, Shimodaira Y, Nomura E, Kikuchi T, Chiba H, Oomori S, Kudo H, Kumada K, Nagaie S, Ogishima S, Nagami F, Shimoyama Y, Moroi R, Kuroha M, Kakuta Y, Ishige T, Kinouchi Y, Masamune A. Shiga H, et al. Among authors: shimodaira y. Scand J Gastroenterol. 2023 Apr;58(4):360-367. doi: 10.1080/00365521.2022.2132831. Epub 2022 Oct 12. Scand J Gastroenterol. 2023. PMID: 36222610

2

Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa.

Arai T, Kakuta Y, Kinouchi Y, Kimura T, Negoro K, Aihara H, Endo K, Shiga H, Kanazawa Y, Kuroha M, Moroi R, Nagasawa H, Shimodaira Y, Takahashi S, Shimosegawa T. Arai T, et al. Among authors: shimodaira y. Hum Immunol. 2011 Jul;72(7):587-91. doi: 10.1016/j.humimm.2011.03.023. Epub 2011 Apr 8. Hum Immunol. 2011. PMID: 21514341

3

[Clinical courses and pregnancy outcomes in Japanese women with inflammatory bowel disease].

Endo K, Takahashi S, Shimodaira Y, Nagasawa H, Moroi R, Kuroha M, Arai T, Kanazawa Y, Shiga H, Kakuta Y, Kinouchi Y, Shimosegawa T. Endo K, et al. Among authors: shimodaira y. Nihon Shokakibyo Gakkai Zasshi. 2011 Nov;108(11):1858-71. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 22056707 Japanese.

4

FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.

Moroi R, Endo K, Kinouchi Y, Shiga H, Kakuta Y, Kuroha M, Kanazawa Y, Shimodaira Y, Horiuchi T, Takahashi S, Shimosegawa T. Moroi R, et al. Among authors: shimodaira y. Immunogenetics. 2013 Apr;65(4):265-71. doi: 10.1007/s00251-013-0679-8. Epub 2013 Jan 29. Immunogenetics. 2013. PMID: 23358932

5

Modulation of endoplasmic reticulum (ER) stress-induced autophagy by C/EBP homologous protein (CHOP) and inositol-requiring enzyme 1α (IRE1α) in human colon cancer cells.

Shimodaira Y, Takahashi S, Kinouchi Y, Endo K, Shiga H, Kakuta Y, Kuroha M, Shimosegawa T. Shimodaira Y, et al. Biochem Biophys Res Commun. 2014 Mar 7;445(2):524-33. doi: 10.1016/j.bbrc.2014.02.054. Epub 2014 Feb 21. Biochem Biophys Res Commun. 2014. PMID: 24565834

6

Erratum to: FCGR3A-158 polymorphism influences the biological response to infliximab in Crohn's disease through affecting the ADCC activity.

Moroi R, Endo K, Kinouchi Y, Shiga H, Kakuta Y, Kuroha M, Kanazawa Y, Shimodaira Y, Horiuchi T, Takahashi S, Shimosegawa T. Moroi R, et al. Among authors: shimodaira y. Immunogenetics. 2015 Sep;67(9):545. doi: 10.1007/s00251-015-0861-2. Immunogenetics. 2015. PMID: 26245508 No abstract available.

7

MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6.

Tadano T, Kakuta Y, Hamada S, Shimodaira Y, Kuroha M, Kawakami Y, Kimura T, Shiga H, Endo K, Masamune A, Takahashi S, Kinouchi Y, Shimosegawa T. Tadano T, et al. Among authors: shimodaira y. World J Gastrointest Oncol. 2016 Jul 15;8(7):532-42. doi: 10.4251/wjgo.v8.i7.532. World J Gastrointest Oncol. 2016. PMID: 27559432 Free PMC article.

8

Association of residual gastric acid secretion with persistent symptoms in gastroesophageal reflux disease patients receiving standard-dose proton pump inhibitor therapy.

Kikuchi H, Fukuda S, Koike T, Shimodaira Y, Watanabe K, Saito M, Nakagawa K, Hatta W, Masamune A, Iijima K. Kikuchi H, et al. Among authors: shimodaira y. Esophagus. 2021 Apr;18(2):380-387. doi: 10.1007/s10388-020-00765-2. Epub 2020 Jul 31. Esophagus. 2021. PMID: 32737802

9

Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis.

Shimodaira Y, Watanabe K, Fukuda S, Watanabe N, Koizumi S, Matsuhashi T, Onochi K, Iijima K. Shimodaira Y, et al. Scand J Gastroenterol. 2022 Feb;57(2):165-168. doi: 10.1080/00365521.2021.1991467. Epub 2021 Oct 18. Scand J Gastroenterol. 2022. PMID: 34663142

10

Visceral obesity is associated with an increased risk of developing esophago-gastric junctional adenocarcinoma in Japan: a population-based case-control study in Akita Prefecture.

Watanabe K, Koizumi S, Shirane K, Tsuda H, Watanabe H, Tsuji T, Onochi K, Yamai K, Kusano C, Dohmen T, Horikawa Y, Ajimine T, Saito M, Koike T, Masamune A, Shimodaira Y, Matsuhashi T, Iijima K. Watanabe K, et al. Among authors: shimodaira y. Esophagus. 2022 Jul;19(3):477-485. doi: 10.1007/s10388-021-00906-1. Epub 2022 Jan 6. Esophagus. 2022. PMID: 34993674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page